Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
Mov Disord ; 37(6): 1164-1174, 2022 06.
Article in English | MEDLINE | ID: mdl-35485341

ABSTRACT

BACKGROUND: The network pathophysiology underlying the motor symptoms of Parkinson's disease (PD) is poorly understood. In models of late-stage PD, there is significant cell-specific remodeling of corticostriatal, axospinous glutamatergic synapses on principal spiny projection neurons (SPNs). Neurons in the centrolateral nucleus (CLN) of the thalamus that relay cerebellar activity to the striatum also make axospinous synapses on SPNs, but the extent to which they are affected in PD has not been definitively characterized. OBJECTIVE: To fill this gap, transgenic mice in which CLN neurons express Cre recombinase were used in conjunction with optogenetic and circuit mapping approaches to determine changes in the CLN projection to SPNs in a unilateral 6-hydroxydopamine (6-OHDA) model of late-stage PD. METHODS: Adeno-associated virus vectors carrying Cre-dependent opsin expression constructs were stereotaxically injected into the CLN of Grp-KH288 mice in which CLN, but not parafascicular nucleus neurons, expressed Cre recombinase. The properties of this projection to identify direct pathway spiny projection neurons (dSPNs) and indirect pathway spiny projection neurons (iSPNs) were then studied in ex vivo brain slices of the dorsolateral striatum from control and 6-OHDA lesioned mice using anatomic, optogenetic, and electrophysiological approaches. RESULTS: Optogenetically evoked excitatory synaptic currents in both iSPNs and dSPNs were reduced in lesioned mice; however, the reduction was significantly greater in dSPNs. In iSPNs, the reduction in evoked responses was attributable to synaptic pruning, because synaptic channelrhodopsin assisted circuit mapping (sCRACm) revealed fewer synapses per cell after lesioning. In contrast, sCRACm mapping of CLN inputs to dSPNs failed to detect any change in synapse abundance in lesioned mice. However, the ratio of currents through α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors to those through N-methyl-D-aspartate receptors was significantly reduced in dSPNs. Moreover, the distribution of currents evoked by optical stimulation of individual synapses shifted toward smaller amplitudes by lesioning, suggesting that they had undergone long-term depression. CONCLUSIONS: Taken together, our results demonstrate that the CLN projection to the striatum undergoes a pathway-specific remodeling that could contribute to the circuit imbalance thought to drive the hypokinetic features of PD. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.


Subject(s)
Intralaminar Thalamic Nuclei , Parkinson Disease , Animals , Corpus Striatum/metabolism , Disease Models, Animal , Humans , Mice , Mice, Transgenic , Oxidopamine/toxicity , Synapses/physiology
2.
Eur J Neurosci ; 47(10): 1148-1158, 2018 05.
Article in English | MEDLINE | ID: mdl-28677242

ABSTRACT

Giant, aspiny cholinergic interneurons (ChIs) have long been known to be key nodes in the striatal circuitry controlling goal-directed actions and habits. In recent years, new experimental approaches, like optogenetics and monosynaptic rabies virus mapping, have expanded our understanding of how ChIs contribute to the striatal activity underlying action selection and the interplay of dopaminergic and cholinergic signaling. These approaches also have begun to reveal how ChI function is distorted in disease states affecting the basal ganglia, like Parkinson's disease (PD). This review gives a brief overview of our current understanding of the functional role played by ChIs in striatal physiology and how this changes in PD. The translational implications of these discoveries, as well as the gaps that remain to be bridged, are discussed as well.


Subject(s)
Cholinergic Neurons/physiology , Corpus Striatum/physiopathology , Interneurons/physiology , Parkinson Disease/physiopathology , Animals , Corpus Striatum/metabolism , Humans , Parkinson Disease/metabolism
3.
Proc Natl Acad Sci U S A ; 109(30): 12195-200, 2012 Jul 24.
Article in English | MEDLINE | ID: mdl-22783023

ABSTRACT

The endocannabinoid 2-arachidonoylglycerol (2-AG) mediates retrograde synaptic suppression. Although the mechanisms of 2-AG production are well characterized, how 2-AG is degraded is less clearly understood. Here we found that expression of the 2-AG hydrolyzing enzyme monoacylglycerol lipase (MGL) was highly heterogeneous in the cerebellum, being rich within parallel fiber (PF) terminals, weak in Bergman glia (BG), and absent in other synaptic terminals. Despite this highly selective MGL expression pattern, 2-AG-mediated retrograde suppression was significantly prolonged at not only PF-Purkinje cell (PC) synapses but also climbing fiber-PC synapses in granule cell-specific MGL knockout (MGL-KO) mice whose cerebellar MGL expression was confined to the BG. Virus-mediated expression of MGL into the BG of global MGL-KO mice significantly shortened 2-AG-mediated retrograde suppression at PF-PC synapses. Furthermore, contribution of MGL to termination of 2-AG signaling depended on the distance from MGL-rich PFs to inhibitory synaptic terminals. Thus, 2-AG is degraded in a synapse-type independent manner by MGL present in PFs and the BG. The results of the present study strongly suggest that MGL regulates 2-AG signaling rather broadly within a certain range of neural tissue, although MGL expression is heterogeneous and limited to a subset of nerve terminals and astrocytes.


Subject(s)
Arachidonic Acids/metabolism , Cannabinoid Receptor Modulators/metabolism , Endocannabinoids , Glycerides/metabolism , Monoacylglycerol Lipases/metabolism , Proteolysis , Signal Transduction/physiology , Synaptic Transmission/physiology , Analysis of Variance , Animals , Calcium/metabolism , Cloning, Molecular , DNA Primers/genetics , Excitatory Postsynaptic Potentials/physiology , Immunohistochemistry , Mice , Mice, Knockout , Monoacylglycerol Lipases/genetics , Neuroglia/metabolism , Polymerase Chain Reaction , Purkinje Cells/metabolism
4.
Cell Rep ; 43(8): 114540, 2024 Aug 27.
Article in English | MEDLINE | ID: mdl-39058595

ABSTRACT

Long-term synaptic plasticity at glutamatergic synapses on striatal spiny projection neurons (SPNs) is central to learning goal-directed behaviors and habits. Our studies reveal that SPNs manifest a heterosynaptic, nitric oxide (NO)-dependent form of long-term postsynaptic depression of glutamatergic SPN synapses (NO-LTD) that is preferentially engaged at quiescent synapses. Plasticity is gated by Ca2+ entry through CaV1.3 Ca2+ channels and phosphodiesterase 1 (PDE1) activation, which blunts intracellular cyclic guanosine monophosphate (cGMP) and NO signaling. Both experimental and simulation studies suggest that this Ca2+-dependent regulation of PDE1 activity allows for local regulation of dendritic cGMP signaling. In a mouse model of Parkinson disease (PD), NO-LTD is absent because of impaired interneuronal NO release; re-balancing intrastriatal neuromodulatory signaling restores NO release and NO-LTD. Taken together, these studies provide important insights into the mechanisms governing NO-LTD in SPNs and its role in psychomotor disorders such as PD.


Subject(s)
Cyclic Nucleotide Phosphodiesterases, Type 1 , Neuronal Plasticity , Neurons , Synapses , Animals , Synapses/metabolism , Neuronal Plasticity/physiology , Mice , Cyclic Nucleotide Phosphodiesterases, Type 1/metabolism , Neurons/metabolism , Nitric Oxide/metabolism , Corpus Striatum/metabolism , Cyclic GMP/metabolism , Glutamic Acid/metabolism , Calcium/metabolism , Mice, Inbred C57BL , Male , Long-Term Synaptic Depression/physiology
5.
bioRxiv ; 2024 Apr 25.
Article in English | MEDLINE | ID: mdl-38712260

ABSTRACT

Long-term synaptic plasticity at glutamatergic synapses on striatal spiny projection neurons (SPNs) is central to learning goal-directed behaviors and habits. Although considerable attention has been paid to the mechanisms underlying synaptic strengthening and new learning, little scrutiny has been given to those involved in the attenuation of synaptic strength that attends suppression of a previously learned association. Our studies revealed a novel, non-Hebbian, long-term, postsynaptic depression of glutamatergic SPN synapses induced by interneuronal nitric oxide (NO) signaling (NO-LTD) that was preferentially engaged at quiescent synapses. This form of plasticity was gated by local Ca 2+ influx through CaV1.3 Ca 2+ channels and stimulation of phosphodiesterase 1 (PDE1), which degraded cyclic guanosine monophosphate (cGMP) and blunted NO signaling. Consistent with this model, mice harboring a gain-of-function mutation in the gene coding for the pore-forming subunit of CaV1.3 channels had elevated depolarization-induced dendritic Ca 2+ entry and impaired NO-LTD. Extracellular uncaging of glutamate and intracellular uncaging of cGMP suggested that this Ca 2+ -dependent regulation of PDE1 activity allowed for local regulation of dendritic NO signaling. This inference was supported by simulation of SPN dendritic integration, which revealed that dendritic spikes engaged PDE1 in a branch-specific manner. In a mouse model of Parkinson's disease (PD), NO-LTD was absent not because of a postsynaptic deficit in NO signaling machinery, but rather due to impaired interneuronal NO release. Re-balancing intrastriatal neuromodulatory signaling in the PD model restored NO release and NO-LTD. Taken together, these studies provide novel insights into the mechanisms governing NO-LTD in SPN and its role in psychomotor disorders, like PD.

6.
J Physiol ; 591(19): 4765-76, 2013 Oct 01.
Article in English | MEDLINE | ID: mdl-23858009

ABSTRACT

The endocannabinoid (eCB) 2-arachidonoylglycerol (2-AG) produced by diacylglycerol lipase α (DGLα) is one of the best-characterized retrograde messengers at central synapses. It has been thought that 2-AG is produced 'on demand' upon activation of postsynaptic neurons. However, recent studies propose that 2-AG is pre-synthesized by DGLα and stored in neurons, and that 2-AG is released from such 'pre-formed pools' without the participation of DGLα. To address whether the 2-AG source for retrograde signalling is the on-demand biosynthesis by DGLα or the mobilization from pre-formed pools, we examined the effects of acute pharmacological inhibition of DGL by a novel potent DGL inhibitor, OMDM-188, on retrograde eCB signalling triggered by Ca(2+) elevation, Gq/11 protein-coupled receptor activation or synergy of these two stimuli in postsynaptic neurons. We found that pretreatment for 1 h with OMDM-188 effectively blocked depolarization-induced suppression of inhibition (DSI), a purely Ca(2+)-dependent form of eCB signalling, in slices from the hippocampus, striatum and cerebellum. We also found that at parallel fibre-Purkinje cell synapses in the cerebellum OMDM-188 abolished synaptically induced retrograde eCB signalling, which is known to be caused by the synergy of postsynaptic Ca(2+) elevation and group I metabotropic glutamate receptor (I-mGluR) activation. Moreover, brief OMDM-188 treatments for several minutes were sufficient to suppress both DSI and the I-mGluR-induced retrograde eCB signalling in cultured hippocampal neurons. These results are consistent with the hypothesis that 2-AG for synaptic retrograde signalling is supplied as a result of on-demand biosynthesis by DGLα rather than mobilization from presumptive pre-formed pools.


Subject(s)
Arachidonic Acids/biosynthesis , Endocannabinoids/biosynthesis , Glycerides/biosynthesis , Lipoprotein Lipase/antagonists & inhibitors , Synaptic Transmission , Animals , Brain/cytology , Brain/metabolism , Calcium/metabolism , GTP-Binding Protein alpha Subunits, Gq-G11/metabolism , Isoleucine/analogs & derivatives , Isoleucine/pharmacology , Lactones/pharmacology , Lipoprotein Lipase/metabolism , Mice , Mice, Inbred C57BL , Purkinje Cells/metabolism , Purkinje Cells/physiology , Receptors, Metabotropic Glutamate/metabolism , Synapses/metabolism , Synapses/physiology
7.
EMBO J ; 28(23): 3717-29, 2009 Dec 02.
Article in English | MEDLINE | ID: mdl-19834457

ABSTRACT

Major depressive and bipolar disorders are serious illnesses that affect millions of people. Growing evidence implicates glutamate signalling in depression, though the molecular mechanism by which glutamate signalling regulates depression-related behaviour remains unknown. In this study, we provide evidence suggesting that tyrosine phosphorylation of the NMDA receptor, an ionotropic glutamate receptor, contributes to depression-related behaviour. The NR2A subunit of the NMDA receptor is tyrosine-phosphorylated, with Tyr 1325 as its one of the major phosphorylation site. We have generated mice expressing mutant NR2A with a Tyr-1325-Phe mutation to prevent the phosphorylation of this site in vivo. The homozygous knock-in mice show antidepressant-like behaviour in the tail suspension test and in the forced swim test. In the striatum of the knock-in mice, DARPP-32 phosphorylation at Thr 34, which is important for the regulation of depression-related behaviour, is increased. We also show that the Tyr 1325 phosphorylation site is required for Src-induced potentiation of the NMDA receptor channel in the striatum. These data argue that Tyr 1325 phosphorylation regulates NMDA receptor channel properties and the NMDA receptor-mediated downstream signalling to modulate depression-related behaviour.


Subject(s)
Depression/metabolism , Depression/physiopathology , Receptors, N-Methyl-D-Aspartate/physiology , Tyrosine/physiology , Animals , Cell Line , Depression/genetics , Depression/psychology , Disease Models, Animal , Down-Regulation/genetics , Gene Knock-In Techniques , Humans , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Phenylalanine/genetics , Phosphorylation/genetics , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Receptors, N-Methyl-D-Aspartate/genetics , Receptors, N-Methyl-D-Aspartate/metabolism , Signal Transduction/genetics , Tyrosine/genetics
8.
J Neurosci ; 31(21): 7700-14, 2011 May 25.
Article in English | MEDLINE | ID: mdl-21613483

ABSTRACT

2-Arachidonoylglycerol (2-AG) is the endocannabinoid that mediates retrograde suppression of neurotransmission in the brain. In the present study, we investigated the 2-AG signaling system at mossy cell (MC)-granule cell (GC) synapses in the mouse dentate gyrus, an excitatory recurrent circuit where endocannabinoids are thought to suppress epileptogenesis. First, we showed by electrophysiology that 2-AG produced by diacylglycerol lipase α (DGLα) mediated both depolarization-induced suppression of excitation and its enhancement by group I metabotropic glutamate receptor activation at MC-GC synapses, as they were abolished in DGLα-knock-out mice. Immunohistochemistry revealed that DGLα was enriched in the neck portion of GC spines forming synapses with MC terminals, whereas cannabinoid CB(1) receptors accumulated in the terminal portion of MC axons. On the other hand, the major 2-AG-degrading enzyme, monoacylglycerol lipase (MGL), was absent at MC-GC synapses but was expressed in astrocytes and some inhibitory terminals. Serial electron microscopy clarified that a given GC spine was innervated by a single MC terminal and also contacted nonsynaptically by other MC terminals making synapses with other GC spines in the neighborhood. MGL-expressing elements, however, poorly covered GC spines, amounting to 17% of the total surface of GC spines by astrocytes and 4% by inhibitory terminals. Our findings provide a basis for 2-AG-mediated retrograde suppression of MC-GC synaptic transmission and also suggest that 2-AG released from activated GC spines is readily accessible to nearby MC-GC synapses by escaping from enzymatic degradation. This molecular-anatomical configuration will contribute to adjust network activity in the dentate gyrus after enhanced excitation.


Subject(s)
Arachidonic Acids/physiology , Dentate Gyrus/physiology , Glycerides/physiology , Mossy Fibers, Hippocampal/physiology , Signal Transduction/physiology , Synapses/physiology , Animals , Dentate Gyrus/cytology , Dentate Gyrus/ultrastructure , Endocannabinoids , Mice , Mice, Inbred C57BL , Mice, Knockout , Mossy Fibers, Hippocampal/ultrastructure , Synapses/ultrastructure
9.
Article in Japanese | MEDLINE | ID: mdl-21800700

ABSTRACT

Marijuana smoking elicits various psychoactive effects through type 1 cannabinoid receptors (CB(1)Rs) in the brain. CB(1)R is a seven-transmembrane domain. G(i/o)-protein coupled receptors, and is expressed throughout the central nervous system including the hippocampus, cerebellum, striatum and cerebral cortex. Endogenous ligands for CB(1)R (endocannabinoids) are lipid in nature, and anandamide and 2-arachidonoylglycerol (2-AG) are considered to be the two major endocannabinoids. Endocannabinoids are known to function as retrograde messengers at synapses. Endocannabinoids are released from postsynaptic neurons in activity-dependent manners, and retrogradely activate presynaptic CB(1)Rs, resulting in short-term or long-term suppression of synaptic transmission. Endocannabinoid-mediated retrograde signaling is observed at various brain regions and considered as a general mechanism of synaptic modulation in the brain. Endocannabinoid release is triggered by postsynaptic Ca2+ elevation or activation of G(q/11)-protein coupled receptors. Recent studies have demonstrated that 2-AG mediates retrograde signaling at synapses in the brain. Endocannabinoid-mediated retrograde signaling is involved in long-term synaptic plasticity in several brain regions. At behavioral level, endocannabinoid signaling is known to be involved in hippocampus-, amygdala- and cerebellum-dependent learning and memory.


Subject(s)
Cannabinoid Receptor Modulators/physiology , Endocannabinoids , Synaptic Transmission/physiology , Animals , Brain/physiology , Neuronal Plasticity/physiology
10.
Neuron ; 101(3): 444-458.e6, 2019 02 06.
Article in English | MEDLINE | ID: mdl-30658860

ABSTRACT

The motor symptoms of Parkinson's disease (PD) are thought to stem from an imbalance in the activity of striatal direct- and indirect-pathway spiny projection neurons (SPNs). Disease-induced alterations in the activity of networks controlling SPNs could contribute to this imbalance. One of these networks is anchored by the parafascicular nucleus (PFn) of the thalamus. To determine the role of the PFn in striatal PD pathophysiology, optogenetic, chemogenetic, and electrophysiological tools were used in ex vivo slices from transgenic mice with region-specific Cre recombinase expression. These studies revealed that in parkinsonian mice, the functional connectivity of PFn neurons with indirect pathway SPNs (iSPNs) was selectively enhanced by cholinergic interneurons acting through presynaptic nicotinic acetylcholine receptors (nAChRs) on PFn terminals. Attenuating this network adaptation by chemogenetic or genetic strategies alleviated motor-learning deficits in parkinsonian mice, pointing to a potential new therapeutic strategy for PD patients.


Subject(s)
Cholinergic Neurons/physiology , Corpus Striatum/physiopathology , Excitatory Postsynaptic Potentials , Interneurons/physiology , Parkinson Disease/physiopathology , Thalamus/physiopathology , Animals , Cholinergic Neurons/metabolism , Corpus Striatum/cytology , Glutamic Acid/metabolism , Interneurons/metabolism , Male , Mice , Mice, Inbred C57BL , Parkinson Disease/metabolism , Receptors, Nicotinic/metabolism , Thalamus/cytology
11.
Curr Opin Neurobiol ; 48: 9-16, 2018 02.
Article in English | MEDLINE | ID: mdl-28843800

ABSTRACT

The striatum is a hub in the basal ganglia circuitry controlling goal directed actions and habits. The loss of its dopaminergic (DAergic) innervation in Parkinson's disease (PD) disrupts the ability of the two principal striatal projection systems to respond appropriately to cortical and thalamic signals, resulting in the hypokinetic features of the disease. New tools to study brain circuitry have led to significant advances in our understanding of striatal circuits and how they adapt in PD models. This short review summarizes some of these recent studies and the gaps that remain to be filled.


Subject(s)
Corpus Striatum/pathology , Neural Pathways/pathology , Parkinson Disease/pathology , Synapses/pathology , Animals , Dopamine/metabolism , Humans , Synapses/metabolism
13.
Nat Commun ; 8(1): 195, 2017 08 04.
Article in English | MEDLINE | ID: mdl-28775326

ABSTRACT

Elimination of early-formed redundant synapses during postnatal development is essential for functional neural circuit formation. Purkinje cells (PCs) in the neonatal cerebellum are innervated by multiple climbing fibers (CFs). A single CF is strengthened whereas the other CFs are eliminated in each PC dependent on postsynaptic activity in PC, but the underlying mechanisms are largely unknown. Here, we report that brain-derived neurotrophic factor (BDNF) from PC facilitates CF synapse elimination. By PC-specific deletion of BDNF combined with knockdown of BDNF receptors in CF, we show that BDNF acts retrogradely on TrkB in CFs, and facilitates elimination of CF synapses from PC somata during the third postnatal week. We also show that BDNF shares signaling pathway with metabotropic glutamate receptor 1, a key molecule that triggers a canonical pathway for CF synapse elimination. These results indicate that unlike other synapses, BDNF mediates punishment signal for synapse elimination in the developing cerebellum.During development, synapses are selectively strengthened or eliminated by activity-dependent competition. Here, the authors show that BDNF-TrkB retrograde signaling is a "punishment" signal that leads to elimination of climbing fiber-onto-Purkinje cell synapses in the developing cerebellum.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Cerebellum/growth & development , Receptor, trkB/metabolism , Synapses/metabolism , Animals , Animals, Newborn , Brain-Derived Neurotrophic Factor/genetics , Cerebellum/metabolism , Mice , Mice, Knockout , Purkinje Cells/metabolism , Receptor, trkB/genetics , Signal Transduction , Synapses/genetics
15.
Front Syst Neurosci ; 10: 102, 2016.
Article in English | MEDLINE | ID: mdl-28018188

ABSTRACT

Huntington's disease (HD) is a neurodegenerative disorder characterized by deficits in movement control that are widely viewed as stemming from pathophysiological changes in the striatum. Giant, aspiny cholinergic interneurons (ChIs) are key elements in the striatal circuitry controlling movement, but whether their physiological properties are intact in the HD brain is unclear. To address this issue, the synaptic properties of ChIs were examined using optogenetic approaches in the Q175 mouse model of HD. In ex vivo brain slices, synaptic facilitation at thalamostriatal synapses onto ChIs was reduced in Q175 mice. The alteration in thalamostriatal transmission was paralleled by an increased response to optogenetic stimulation of cortical axons, enabling these inputs to more readily induce burst-pause patterns of activity in ChIs. This adaptation was dependent upon amplification of cortically evoked responses by a post-synaptic upregulation of voltage-dependent Na+ channels. This upregulation also led to an increased ability of somatic spikes to invade ChI dendrites. However, there was not an alteration in the basal pacemaking rate of ChIs, possibly due to increased availability of Kv4 channels. Thus, there is a functional "re-wiring" of the striatal networks in Q175 mice, which results in greater cortical control of phasic ChI activity, which is widely thought to shape the impact of salient stimuli on striatal action selection.

16.
Nat Commun ; 7: 10594, 2016 Feb 03.
Article in English | MEDLINE | ID: mdl-26839058

ABSTRACT

Intracellular trafficking of receptor proteins is essential for neurons to detect various extracellular factors during the formation and refinement of neural circuits. However, the precise mechanisms underlying the trafficking of neurotrophin receptors to synapses remain elusive. Here, we demonstrate that a brain-enriched sorting nexin, ARHGAP33, is a new type of regulator for the intracellular trafficking of TrkB, a high-affinity receptor for brain-derived neurotrophic factor. ARHGAP33 knockout (KO) mice exhibit reduced expression of synaptic TrkB, impaired spine development and neuropsychiatric disorder-related behavioural abnormalities. These deficits are rescued by specific pharmacological enhancement of TrkB signalling in ARHGAP33 KO mice. Mechanistically, ARHGAP33 interacts with SORT1 to cooperatively regulate TrkB trafficking. Human ARHGAP33 is associated with brain phenotypes and reduced SORT1 expression is found in patients with schizophrenia. We propose that ARHGAP33/SORT1-mediated TrkB trafficking is essential for synapse development and that the dysfunction of this mechanism may be a new molecular pathology of neuropsychiatric disorders.


Subject(s)
Adaptor Proteins, Vesicular Transport/metabolism , Behavior, Animal , Dendritic Spines/genetics , GTPase-Activating Proteins/genetics , Neurons/metabolism , Protein Transport/genetics , RNA, Messenger/metabolism , Receptor, trkB/metabolism , Schizophrenia/genetics , Sorting Nexins/genetics , Synapses/genetics , Adult , Animals , Brain/metabolism , Brain/pathology , Case-Control Studies , Cells, Cultured , Dendritic Spines/metabolism , Female , GTPase-Activating Proteins/metabolism , HEK293 Cells , Hippocampus/cytology , Hippocampus/metabolism , Humans , Immunoblotting , Immunohistochemistry , In Situ Hybridization , Magnetic Resonance Imaging , Male , Mice , Mice, Knockout , Middle Aged , Patch-Clamp Techniques , Phenotype , Polymorphism, Single Nucleotide , Real-Time Polymerase Chain Reaction , Schizophrenia/metabolism , Schizophrenia/pathology , Sorting Nexins/metabolism , Synapses/metabolism
17.
Cell Rep ; 13(7): 1336-1342, 2015 Nov 17.
Article in English | MEDLINE | ID: mdl-26549446

ABSTRACT

Experience-driven plasticity of glutamatergic synapses on striatal spiny projection neurons (SPNs) is thought to be essential to goal-directed behavior and habit formation. One major form of striatal plasticity, long-term depression (LTD), has long appeared to be expressed only pre-synaptically. Contrary to this view, nitric oxide (NO) generated by striatal interneurons was found to induce a post-synaptically expressed form of LTD at SPN glutamatergic synapses. This form of LTD was dependent on signaling through guanylyl cyclase and protein kinase G, both of which are abundantly expressed by SPNs. NO-LTD was unaffected by local synaptic activity or antagonism of endocannabinoid (eCb) and dopamine receptors, all of which modulate canonical, pre-synaptic LTD. Moreover, NO signaling disrupted induction of this canonical LTD by inhibiting dendritic Ca(2+) channels regulating eCb synthesis. These results establish an interneuron-dependent, heterosynaptic form of post-synaptic LTD that could act to promote stability of the striatal network during learning.


Subject(s)
Interneurons/physiology , Long-Term Synaptic Depression , Nitric Oxide/physiology , Animals , Excitatory Postsynaptic Potentials , Glutamic Acid/physiology , Mice , Optogenetics , Synapses
18.
Neuropsychopharmacology ; 40(7): 1569-79, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25662838

ABSTRACT

An increase in the ratio of cellular excitation to inhibition (E/I ratio) has been proposed to underlie the pathogenesis of neuropsychiatric disorders, such as autism spectrum disorders (ASD), obsessive-compulsive disorder (OCD), and Tourette's syndrome (TS). A proper E/I ratio is achieved via factors expressed in neuron and glia. In astrocytes, the glutamate transporter GLT1 is critical for regulating an E/I ratio. However, the role of GLT1 dysfunction in the pathogenesis of neuropsychiatric disorders remains unknown because mice with a complete deficiency of GLT1 exhibited seizures and premature death. Here, we show that astrocyte-specific GLT1 inducible knockout (GLAST(CreERT2/+)/GLT1(flox/flox), iKO) mice exhibit pathological repetitive behaviors including excessive and injurious levels of self-grooming and tic-like head shakes. Electrophysiological studies reveal that excitatory transmission at corticostriatal synapse is normal in a basal state but is increased after repetitive stimulation. Furthermore, treatment with an N-methyl-D-aspartate (NMDA) receptor antagonist memantine ameliorated the pathological repetitive behaviors in iKO mice. These results suggest that astroglial GLT1 has a critical role in controlling the synaptic efficacy at corticostriatal synapses and its dysfunction causes pathological repetitive behaviors.


Subject(s)
Cerebral Cortex/pathology , Cumulative Trauma Disorders/genetics , Cumulative Trauma Disorders/pathology , Excitatory Amino Acid Transporter 1/deficiency , Excitatory Amino Acid Transporter 2/deficiency , Synapses/genetics , Animals , Animals, Newborn , Anxiety/genetics , Cumulative Trauma Disorders/complications , Cumulative Trauma Disorders/drug therapy , Disease Models, Animal , Enzyme Inhibitors/therapeutic use , Excitatory Amino Acid Transporter 1/genetics , Excitatory Amino Acid Transporter 2/genetics , Excitatory Postsynaptic Potentials/genetics , Female , Gene Expression Regulation/genetics , Hyperalgesia/genetics , Male , Mice , Mice, Transgenic , Nerve Degeneration/etiology , Nerve Degeneration/genetics , Nerve Tissue Proteins/metabolism , Proteins/genetics , Seizures/genetics
19.
Neuron ; 78(5): 839-54, 2013 Jun 05.
Article in English | MEDLINE | ID: mdl-23684785

ABSTRACT

Highly topographic organization of neural circuits exists for the regulation of various brain functions in corticobasal ganglia circuits. Although neural circuit-specific refinement during synapse development is essential for the execution of particular neural functions, the molecular and cellular mechanisms for synapse refinement are largely unknown. Here, we show that protocadherin 17 (PCDH17), one of the nonclustered δ2-protocadherin family members, is enriched along corticobasal ganglia synapses in a zone-specific manner during synaptogenesis and regulates presynaptic assembly in these synapses. PCDH17 deficiency in mice causes facilitated presynaptic vesicle accumulation and enhanced synaptic transmission efficacy in corticobasal ganglia circuits. Furthermore, PCDH17(-/-) mice exhibit antidepressant-like phenotypes that are known to be regulated by corticobasal ganglia circuits. Our findings demonstrate a critical role for PCDH17 in the synaptic development of specific corticobasal ganglia circuits and suggest the involvement of PCDH17 in such circuits in depressive behaviors.


Subject(s)
Basal Ganglia/cytology , Cadherins/physiology , Cerebral Cortex/cytology , Neurons/physiology , Presynaptic Terminals/physiology , Synapses/genetics , Acoustic Stimulation , Animals , Animals, Newborn , Cadherins/genetics , Cadherins/metabolism , Cell Line, Transformed , Conditioning, Psychological/physiology , Cricetinae , Cricetulus , Disks Large Homolog 4 Protein , Exploratory Behavior , Fear/physiology , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Guanylate Kinases/metabolism , Hindlimb Suspension/physiology , Humans , In Vitro Techniques , Macaca mulatta , Male , Maze Learning/physiology , Membrane Potentials/genetics , Membrane Proteins/metabolism , Mice , Mice, Transgenic , Microscopy, Electron , Nerve Net/physiology , Neurons/metabolism , Neurons/ultrastructure , Patch-Clamp Techniques , Protocadherins , Swimming/physiology , Synapses/metabolism , Synapses/ultrastructure , Synaptic Transmission/genetics , Synaptic Vesicles/metabolism , Synaptic Vesicles/ultrastructure , Vesicular Glutamate Transport Proteins/metabolism
20.
Neuroscientist ; 18(2): 119-32, 2012 Apr.
Article in English | MEDLINE | ID: mdl-21531987

ABSTRACT

Since the first reports of endocannabinoid-mediated retrograde signaling in 2001, great advances have been made toward understanding the molecular basis and functions of the endocannabinoid system. Electrophysiological studies have revealed that the endocannabinoid system is functional at various types of synapses throughout the brain. Basic mechanisms have been clarified as to how endocannabinoids are produced and released from postsynaptic neurons and regulate neurotransmitter release through activating presynaptic cannabinoid CB(1) receptors, although there remain unsolved questions and some discrepancies. In addition to this major function, recent studies suggest diverse functions of endocannabinoids, including control of other endocannabinoid-independent forms of synaptic plasticity, regulation of neuronal excitability, stimulation of glia-neuron interaction, and induction of CB(1)R-independent plasticity. Using recently developed pharmacological and genetic tools, behavioral studies have elucidated the roles of the endocannabinoid system in various aspects of neural functions. In this review, we make a brief overview of molecular mechanisms underlying the endocannabinoid-mediated synaptic modulation and also summarize recent findings, which shed new light on a diversity of functional roles of endocannabinoids.


Subject(s)
Cannabinoid Receptor Modulators/physiology , Endocannabinoids , Synaptic Transmission/physiology , Animals , Cell Communication , Humans , Neuronal Plasticity/physiology , Neurotransmitter Agents/physiology , Receptors, Cannabinoid/physiology , Signal Transduction/physiology
SELECTION OF CITATIONS
SEARCH DETAIL